Mutual of America Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Mutual of America Capital Management’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-17,080	Closed	-$422K	–	1256
2015 Q3	$422K	Sell	17,080 -7,474	-30%	-$223K	0.01%	1126
2015 Q2	$788K	Buy	24,554 +2,801	+13%	+$107K	0.02%	1074
2015 Q1	$777K	Hold	21,753	–	–	0.02%	1063
2014 Q4	$495K	Sell	21,753 -20,265	-48%	-$410K	0.01%	1110
2014 Q3	$815K	Buy	42,018 +29,921	+247%	+$845K	0.02%	1043
2014 Q2	$439K	Buy	+12,097	New	+$411K	0.01%	1131

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Mutual of America Capital Management's RIGL Position: Q4 2015 in Review

Mutual of America Capital Management sold out of Rigel Pharmaceuticals (RIGL) in Q4 2015, closing a stake of 17,080 shares — an estimated $422K sold.

Mutual of America Capital Management first reported a position in RIGL in Q2 2014 and held it in 6 quarters. The position peaked at $815K in Q3 2014. 121 funds tracked by Wall St. Rank hold RIGL as of Q4 2015.

Mutual of America Capital Management reported no remaining Rigel Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Mutual of America Capital Management sold 17,080 Rigel Pharmaceuticals shares in Q4 2015, an estimated $422K.
Mutual of America Capital Management first reported a position in Rigel Pharmaceuticals in Q2 2014 and held it in 6 quarters.
Mutual of America Capital Management's Rigel Pharmaceuticals position peaked at $815K in Q3 2014.
121 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2015.

Based on Mutual of America Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.